Companies and laboratories

Castel Romano

TAKIS S.r.l.

Health, Biotechnology and Life Sciences


Luigi Aurisicchio

+39 06 50576077

via Castel Romano 100 - 00128 Roma

Go to the website

Takis is a biotechnology company based in Rome, founded in 2009 by a group of scientists from Merck Research Laboratories (MRL) to develop cancer immunotherapy solutions, aiming to the generation of therapeutic vaccines.

The group has more than 10 years of experience in drug discovery and is recognized for the conception and implementation of a number of innovative technologies with the goal to improve in vivo gene transfer, regulation of gene expression and immunogenicity. Takis has developed a proprietary vaccine technology based on DNA ElectroGeneTransfer to induce potent immune responses against a variety of Antigens. POC of the technology successfully achieved for Cancer Vaccines in Phase 1 trials in humans. Takis has a diverse pipeline of projects based on DNA ElectroGeneTransfer ranging from Cancer, Malaria, and monoclonal antibodies. COVID-eVax is a vaccine against COVID-19 currently in PhaseI/II clinical trial planned to go on the market on 1Q22. In addition, Takis provides specialized Research and Development services to Pharmaceutical companies, Biotech and Academia.

Subscribe to our newsletter
and discover Tecnopolo Roma.

Always stay updated
on how the world of innovation moves.

*All fields marked with an asterisk are mandatory.